Reference health
Influenza A Virus Modulates ACE2 Expression and SARS-CoV-2 Infectivity in Human Cardiomyocytes
32/32 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
16 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 32 checked references that resolve
resolves10.1038/s41588-020-00759-x
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection
resolves10.1093/cvr/cvaa078
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
resolves10.1002/jmv.26817
Co‐infection of influenza A virus and SARS‐CoV‐2: A retrospective cohort study
resolves10.1172/JCI116479
Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.
resolves10.1016/j.bbapap.2004.10.010
Membrane-associated zinc peptidase families: comparing ACE and ACE2
resolves10.1128/JVI.02202-13
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
resolves10.1001/jama.2020.6266
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
resolves10.1002/eji.200535587
Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions
resolves10.1016/j.cmi.2020.07.016
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
resolves10.1007/s00134-020-06205-0
The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19
resolves10.1001/jamacardio.2020.3551
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
resolves10.1016/j.stemcr.2021.02.008
SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function
resolves10.1038/s41588-020-00732-8
Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option
resolves10.1093/eurheartj/ehaa311
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
resolves10.1371/journal.pone.0073637
Cardiomyocyte MEA Data Analysis (CardioMDA) – A Novel Field Potential Data Analysis Software for Pluripotent Stem Cell Derived Cardiomyocytes
resolves10.1016/j.celrep.2017.09.034
M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1
resolves10.1161/01.HYP.0000251865.35728.2f
Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways
resolves10.1093/glycob/cwaa101
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
resolves10.1517/13543784.2012.664131
Angiotensin II type 2 receptor agonists: where should they be applied?
resolves10.1093/infdis/jiz405
Effect of Mycobacterium tuberculosis Enhancement of Macrophage P-Glycoprotein Expression and Activity on Intracellular Survival During Antituberculosis Drug Treatment
resolves10.1016/j.stem.2020.06.015
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
resolves10.1007/s15010-020-01424-5
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights
The 16 references without a DOI — listed, not checked
no DOI — not checkedHuman Type I IFN neutralizing antibody mix (39000-1) was obtained from PBL Assay Science. Anti-ACE2 antibody (10108-T56 and T60) and anti
no DOI — not checkedCulture of Human induced pluripotent stem cell-derived cardiomyocytes Human iPSC-CMs were plated using the supplier protocol. Briefly, hiPSC-CMs were plated as a monolayer in sterile 12 well cell culture plates coated with 0.1% gelatin and incubated at 37�C and 5% CO 2 in a humidified atmosphere for 48h. Then cells were transferred into CDI maintenance medium for further culture and the maintenance medium was changed every alternate day. For, gelatin coating, 1ml of 0.1% gelatin was added into each well of a 12 well plate and incubated at 37�C for a minimum of 1h. Human iPSC-CMs functional assay with Multi-electrode array system (MEA) After 5-7 days of hiPSC-CMs culturing in the 12 well cell culture plate, the cells were replated onto MEA plate. For this, the sterile 24 well CytoView MEA culture plate (Cat#M384-tMEA-24W
no DOI — not checkedref3
no DOI — not checkedSequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza
no DOI — not checkedAngiotensin converting enzyme 2 is a novel target of the ?-secretase complex
no DOI — not checkedHost Immune Response to Influenza A Virus Infection
no DOI — not checkedSARS-CoV-2 and influenza virus co-infection
no DOI — not checkedref14
no DOI — not checkedDual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
no DOI — not checkedInterferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
no DOI — not checkedref36
no DOI — not checkedref37
no DOI — not checkedOpposing activities of IFITM proteins in SARS-CoV-2 infection
no DOI — not checkedFigure Legends: C57BL/6 mice were infected with IAV-PR68 (1x10 4 PFU) and on day 6 the mice were euthanized to harvest the lungs. The lung sections were stained with anti-ACE2 and macrophage marker F4/80 antibodies, followed by AF594 and AF488 conjugated secondary antibodies respectively. The nuclei were stained with DAPI
no DOI — not checkedref47
no DOI — not checkedData analysis was performed using the cardiac analysis tool. (A) Activity map showing changes in beat rate of cardiomyocytes treated with HK SARS-CoV-2. Shown is a representative well from quadruplicate samples for each treatment (N=2). The graphs shown in B is the number of cardiomyocyte beats per minute at baseline and at 12, 18 and 24h post treatment. Data shown is a representative of two independent experiments performed in quadruplicate wells
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3952087"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3952087/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3952087)